Relief Therapeutics Holding (XSWX:RLF) Long-Term Capital Lease Obligation : CHF2.09 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding Long-Term Capital Lease Obligation?

Relief Therapeutics Holding's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF2.09 Mil.

Relief Therapeutics Holding's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (CHF2.23 Mil) to Jun. 2023 (CHF2.33 Mil) but then declined from Jun. 2023 (CHF2.33 Mil) to Dec. 2023 (CHF2.09 Mil).

Relief Therapeutics Holding's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (CHF2.19 Mil) to Dec. 2022 (CHF2.23 Mil) but then declined from Dec. 2022 (CHF2.23 Mil) to Dec. 2023 (CHF2.09 Mil).

Relief Therapeutics Holding Long-Term Capital Lease Obligation Historical Data

The historical data trend for Relief Therapeutics Holding's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Long-Term Capital Lease Obligation Chart

Relief Therapeutics Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.19

2.23

2.09

Relief Therapeutics Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.19	2.06	2.23	2.33	2.09

Relief Therapeutics Holding (XSWX:RLF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Relief Therapeutics Holding Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (XSWX:RLF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFTF:USA RLFz:UK

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (XSWX:RLF) Headlines

No Headlines